Belgium· BE-AMP-SAM660469-00
Kinpeygo 4 mg
A budesonide product containing budesonide, registered in Belgium by Stada Arzneimittel. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Budesonide is registered in 16 of 19 countries.
Countries holding a registration under ATC A07EA06 (budesonide), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Budesonide · ATC A07EA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of budesonide costs, country by country.
Normalised to the WHO defined daily dose (9 mg), the median price runs from $2.36 in Italy to $4.97 in Switzerland — a ×2.1 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Budesonide · price per daily dose (9 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.97
- IT Italy$2.36
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Budesonide
- Manufacturer
- Stada Arzneimittel
- Country
- Belgium (BE)
- ATC code
- A07EA06
- ATC class
- Budesonide
- Defined daily dose
- 9 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4880316
- be_apb7742117
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
687 interactions on record for budesonide.
Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Budesonide · interactions on record
687 records
- 62 severe
- 260 moderate
- 27 minor
- 337 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- Bempedoic acidC10AX15severe
- MifepristoneG03XB01severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Budesonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKINPEYGOSTADA Arzneimittel AG, Bad Vilbel
- SpainKINPEYGO 4 MG CAPSULAS DURAS DE LIBERACION MODIFICADAStada Arzneimittel Ag
- United KingdomKinpeygo 4mg modified-release capsulesGenus Pharmaceuticals Holdings Ltd
- IrelandKinpeygo 4 mg modified-release hard capsulesStada Arzneimittel AG
- IcelandKinpeygoSTADA Arzneimittel AG
- NetherlandsKinpeygo 4 mg, harde capsules met gereguleerde afgifteStada Arzneimittel AG
- PolandKinpeygoSTADA Arzneimittel AG
- SwedenKinpeygo 4 mg Kapsel med modifierad frisättning, hårdSTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Budenofalk, Budo-San
- Bulgaria · Airbudenid, Буденофалк
- Cyprus · Axelovert, Biosonide
- Czechia · Budenofalk, Budenofalk Uno
- Germany · Aquacort, Budapp Nasal
- Denmark · Benarhin, Budenofalk
- Estonia · Budesonid Sandoz, Budesonide
- Spain · Budena, Budesonida
- Finland · Budenofalk, Budesonid Easyhaler Orion
- France · Budésonide Arrow, Budesonide Biogaran
- United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
- Greece · Aurid, Axelovert
- Croatia · Budelin Novolizer, Budosan
- Hungary · Budenofalk, Budesonid Easyhaler
- Ireland · Budenofalk, Budesonide Azure
- Iceland · Budesonide Stada, Cortiment
- Italy · Aircort, Bidien
- Liechtenstein · Jorveza, Kinpeygo
- Lithuania · Budenofalk, Budesonide Ferring
- Luxembourg · Budenofalk, Budesonide Eg
- Latvia · Budenofalk, Budesonid Sandoz
- Malta · Budesonida Aldo-Unión, Budesonide Azure
- Netherlands · Budenofalk, Budenofalk Schuim
- Norway · Budenofalk, Budesonid Medical Valley
- Poland · Bds N, Benodil
- Portugal · Aeromax, Budenofalk
- Romania · Budenofalk, Budenofalk Uno
- Sweden · Budaxiro, Budenofalk
- Slovenia · Budenofalk, Budesonid Easyhaler Orion
- Slovakia · Budelin Novolizer, Budenofalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2b976e2c-4ceb-4698-bcb8-de2662b3f61f GET /v1/drugs/2b976e2c-4ceb-4698-bcb8-de2662b3f61f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Modified-release capsule, hard",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Kinpeygo 4 mg",
"name_fr": "Kinpeygo 4 mg",
"name_nl": "Kinpeygo 4 mg",
"amp_code": "SAM660469-00",
"strengths": [
"4.0000",
"4.0000",
"4.0000",
"4.0000",
"4.0000",
"230.0000"
],
"pack_count": 4,
"substances": [
"Budesonide",
"Sucrose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Budesonide",
"authorisation_numbers": [
"EU/1/22/1657/001",
"EU/1/22/1657/002",
"EU/1/22/1657/003",
"EU/1/22/1657/004"
]
}See everything about budesonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.